Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Indiva Reports Fiscal Year 2023 Results Including Record Positive EBITDA and Income (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Aphria Inc. APHA

Healthcare Drug Manufacturers - Major Cannabis
Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints... see more

Recent & Breaking News (NDAQ:APHA)

IIROC Trade Resumption - Aphria Inc.

Newsfile November 16, 2016

IIROC Trading Resumption - APH

Canada NewsWire November 16, 2016

IIROC Trade Halt - Aphria Inc.

Newsfile November 16, 2016

IIROC Trading Halt - APH

Canada NewsWire November 16, 2016

Legal Cannabis Market Has High Expectations After Elections

Canada NewsWire November 11, 2016

Aphria Inc. Announces $35 Million Bought Deal

MarketWire Canada November 11, 2016

BTV Uncovers Disruptive Tech, Pharma and Manufacturing Companies

Newsfile November 10, 2016

Tetra Bio-Pharma Enters Into Medical Cannabis Supply Agreement With ACMPR Licensed Producer Aphria Inc.

MarketWire Canada November 3, 2016

Aphria issues stock options

MarketWire Canada November 2, 2016

Cannabis Sector Gaining Major Momentum Ahead of U.S. Elections

PR Newswire November 2, 2016

Aphria welcomes Arlene Dickinson to its Board of Directors

MarketWire Canada October 28, 2016

Aphria enters into IP transfer agreement in Arizona

MarketWire Canada October 27, 2016

Aphria and MassRoots Partner in One of First International Collaborations between Cannabis Companies

MarketWire Canada October 18, 2016

Aphria Reports Quarterly EBITDA of $1 Million

MarketWire Canada October 7, 2016

Aphria Announces Licence Amendment

MarketWire Canada September 26, 2016

Aphria Finalizes Licensing Deal With Tokyo Smoke

MarketWire Canada September 19, 2016

Aphria to Triple Its Production Space as it Starts Part III Expansion

MarketWire Canada September 16, 2016

Aphria Partners With Leading International Consumer Lifestyle Brand Tokyo Smoke

MarketWire Canada September 7, 2016

Medlab and Aphria Complete Cannabis Supply Deal Ahead of Cannabis Human Trial

MarketWire Canada August 22, 2016

Western Areas Conference Call -- Full Year Results to 30 June 2016 -- Updated Time

MarketWire Canada August 22, 2016